Loading provider…
Loading provider…
Medical Oncology Physician in Philadelphia, PA
NPI: 1073892626Primary Practice Location
THOMAS JEFFERSON UNIVERSITY HOSPITAL
900 Walnut St, Philadelphia, PA
Primary Employer
Jefferson University Physicians
jeffersonhealth.org
HQ Phone
Get M.D. Babar's Phone Numberphone_androidMobile
Get M.D. Babar's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
PA State Medical License
PA State Medical License
2010 - 2026
NJ State Medical License
2020 - 2025

American Board of Internal Medicine
Medical Oncology

American Board of Internal Medicine
Internal Medicine
Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
Fellowship • Hematology and Medical Oncology
2017 - 2019
Abington Memorial Hospital
Chief Residency • Internal Medicine
2014 - 2015
Residency • Internal Medicine
2011 - 2014
Internship • Internal Medicine
2011 - 2012
Thomas Jefferson University
Masters • Pharmacology
2015 - 2018
Quaid-e-Azam Medical College
Medical School
Until 2006
Sidney Kimmel Medical College
jefferson.edu
Fellowship • Clinical Pharmacology
2016 - 2018
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 53 | 187 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 24 | 57 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 18 | 18 |
Obesity's Disparate Impact on COVID-19 Outcomes in Asian American Patients with Cancer.
Authors: Julie Leann Fu, Jeremy Warner, Sonya Reid, Oscar Serrano, Sunny R K Singh, David Chism, Clara Hwang, Gayathri Nagaraj
Journal: medRxiv
Publication Date: 2025-05-16
Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers.
Authors: Bloom, Matthew D, Bashir, Babar
Journal: J Gastrointest Oncol
Publication Date: 2024-04-25
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, OTHER: Data Collection
Lead Sponsor: Lyell Immunopharma, Inc.
Intervention / Treatment: BIOLOGICAL: LYL797
Lead Sponsor: Ikena Oncology
Intervention / Treatment: DRUG: Osimertinib, DRUG: IK-930